Clinical Trials Directory

Trials / Sponsors / Xoft, Inc.

Xoft, Inc.

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnAn Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite"
Invasive Ductal Carcinoma, Ductal Carcinoma In Situ
N/A2022-06-30
CompletedPost-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated W
Non-melanoma Skin Cancer
—2022-03-09
TerminatedRecurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab
Glioblastoma, Recurrent Glioblastoma, GBM
Phase 22021-11-02
CompletedComparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort
Nonmelanoma Skin Cancer
—2016-10-01
CompletedFeasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
Cervical Cancer
N/A2013-11-01
Active Not RecruitingSafety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®
Invasive Ductal Carcinoma, Ductal Carcinoma in Situ
N/A2012-05-08
CompletedElectronic Brachytherapy for the Treatment of NMSC
Basal Cell Carcinoma, Squamous Cell Carcinoma
—2009-08-01
CompletedFeasibility Study Using the Xoft System for the Treatment of Endometrial Cancer
Endometrial Cancer
N/A2008-10-01
TerminatedIntra-Operative Radiation Therapy Immediately Following Resection of Early Stage Breast Cancer
Breast Cancer
N/A2008-09-01
CompletedElectronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage
Breast Cancer, Carcinoma, Lumpectomy
Phase 42008-05-01
CompletedPost Market Study Using the Xoft Axxent System
Breast Cancer
N/A2007-03-26